Quantitative characterization of multiple binding sites for phencyclidine and N-allynormetazocine in membranes from rat and guinea pig brain

Cruciani, 1987, Naloxonazine effects on the interaction of enkephalin analogs with Mu-1, Mu and delta opioid binding sites in rat brain membranes, J. Pharmac. exp. Ther., 242, 15 De Lean, 1978, Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves, Am. J. Physiol., 235, E97 Domino, 1981, Abnormal mental states induced by phencyclidine as a model of schizophrenia, 401 Downes, 1986, A comparison of the binding of σ opioids and phencyclidine, and the interaction with antipsychotic drugs in rat brain membranes, Br. J. Pharmac., 88, 231, 10.1111/j.1476-5381.1986.tb09491.x Fagg, 1987, Phencyclidine and related drugs bind to the activated N-methyl-d-aspartate receptor-channel complex in raat membranes, Neurosci. Lett., 76, 221, 10.1016/0304-3940(87)90719-1 Goldman, 1985, Differentiation of [3H]phencyclidine and (+)[3H]SKF10,047 binding sites in rat cerebral cortex, FEBS Lett., 190, 333, 10.1016/0014-5793(85)81313-2 Goldstein, 1987, Binding selectivity profiles for ligands of multiple receptor types: focus on opioid receptors, Trends Neurosci., 8, 456 Gundlach, 1985, Phencyclidine and σ opiate receptors in brain: biochemical and autoradiographical differentiation, Eur. J. Pharmac., 113, 465, 10.1016/0014-2999(85)90100-1 Haertzen, 1970, Subjective effects of narcotic antagonists cyclazocine and nalorphine on the addiction research center inventory (ARCI), Psychopharmacology, 18, 366, 10.1007/BF00402763 Itzhak, 1987, [3H]PCP-3-OH and (+)[3H]SKF10,047 binding sites in the rat membranes: evidence of multiplicity, Eur. J. Pharmac., 136, 231, 10.1016/0014-2999(87)90715-1 Itzhak, 1988, Regulation of the binding sigma and phenyclidine (PCP) receptor ligands in rat brain membranes by guanine nucleotides and ions, Neurosci. Lett., 85, 147, 10.1016/0304-3940(88)90445-4 Itzhak, 1985, Characterization of specific binding sites for [3H](d)-N-allylnormetazocine in rat brain membranes, Molec. Pharmac., 27, 46 Keats, 1984, Narcotic antagonists as analgesics. Clinical aspects, Adv. Chem. Res., 45, 170, 10.1021/ba-1964-0045.ch014 Largent, 1986, σ Receptors on NSB-20 hybrid neurotumor cells labeled with (+)[3H]SKF10,047 and (+)[3H]3-PPP, Eur. J. Pharmac., 124, 183, 10.1016/0014-2999(86)90142-1 Largent, 1984, Psychotomimetic opiate receptors labeled and visualized with (+)-[3H]3-(3-hydroxyphenyl)-N-(1-propyl)piperidine, 81, 4983 Largent, 1986, Pharmacological autoradiographic discimination of σ and phencyclidine receptor binding sites in brain with (+)-SKF10,047, (+)-[3H]3-(3-hdyroxyphenyl)-N-(1-propyl)piperidine and [3H]1-(thienyl-cyclohexyl)-piperidine, J. Pharmac. exp. Ther., 238, 739 Maggi, 1988, Vasopressin and oxytocin receptors in vagina, myometrium, and oviduct of rabbits, Endocrinology, 122, 2970, 10.1210/endo-122-6-2970 Martin, 1976, The effects of morphine- and nalorphine-like drugs in the non-dependent and morphine dependent chronic spinal dog, J. Pharmac. exp. Ther., 197, 517 Mendelsohn, 1985, Sigma opioid receptor: Characterization and co-identity with the phencyclidine receptor, J. Pharmac. exp. Ther., 233, 597 Munson, 1979, Computer modeling of several ligands binding to multiple receptors, Endocrinology, 105, 1377 Munson, 1980, LIGAND: A versatile, computerized approach for characterization of ligand binding system, Analyt. Biochem., 107, 220, 10.1016/0003-2697(80)90515-1 Munson, 1984, Computerized analysis of ligand binding data: basic principles and recent developments, Vol. 14, 117 Munson, 1984, New methods for characterization of complex receptor systems involving three or more binding sites: application to brain opiate receptors, J. Recept. Res., 4, 339, 10.3109/10799898409042560 Pasternak, 1981, The binding and analgesic properties of a sigma opiate, SKF10,047, J. Pharmac. exp. Ther., 219, 192 Pesce, 1987, Characterization of kappa opioid receptors in neurosecretosomes from bovine posterior pituitary, J. Neurochem., 49, 421, 10.1111/j.1471-4159.1987.tb02882.x Pesce, 1990, Computer modeling of subtypes of kappa opioid receptors in adrenal medulla, Eur. J. Pharmac., 182, 429, 10.1016/0014-2999(90)90040-D Quirion, 1981, Phencyclidine (angel dust)/σ “opiate” receptor: Visualization by tritium-sensitive film, 78, 5881 Rachel, 1987, Binding studies and photoaffinity labeling identity two classes of phencyclidine receptors in rat brain, Biochemistry, 26, 5854, 10.1021/bi00392a041 Ranke, 1976, Characterization of somatogenic and lactogenic binding sites in isolated rat hepatocytes, Endocrinology, 99, 1033, 10.1210/endo-99-4-1033 Rodbard, 1986, Computer analysis of radioligand data: Advantage, problems and pitfalls, Vol. 70, 209 Rothman, 1986, Binding surface analysis: an intiutive yet quantitative method for the design and analysis of ligand binding studies, Alcohol Drug Res., 6, 309 Rothman, 1989, The psychotomimetic drug phencyclidine labels two high affinity binding sites in guinea pig brain: evidence for N-methyl-d-aspartate-coupled and dopamine reuptake carrier-associated phencyclidine binding sites, Molec. Pharmac., 36, 887 Rovati, 1988, DESIGN: Computerized optimization of experimental design for ligand binding experiments. I. Homologous and heterologous binding to one or two classes of sites, Analyt. Biochem., 174, 636, 10.1016/0003-2697(88)90067-X Rovati, 1990, DESIGN: Computetized optimization of experimental design for estimating Kd and Bmax in ligand binding experiments. II. Simultaneous analysis of homologous and heterologous competition curves and of “multiligand” dose-response surfaces, Analyt. Biochem., 184, 172, 10.1016/0003-2697(90)90030-D Siegel, 1978, Phencyclidine and ketamine intoxication: a study of four populations of recreational users, 119 Sircar, 1983, Characterization of specific sigma opiate/phencyclidine (PCP) binding sites in the human brain, Life Sci., 33, 259, 10.1016/0024-3205(83)90492-7 Sircar, 1986, Characterization and autoradiographic visualization of (+)[3H]SKF10,047 binding in rat and mouse brain: Further evidence for phencyclidine/“sigma opiate” receptor commonality, J. Pharmac. exp. Ther., 237, 681 Su, 1982, Evidence for σ opioid receptor: binding of (+)[3H]SKF10,047 to etorphine-inaccessible sites in guinea pig brain, J. Pharmac. exp. Ther., 223, 284 Tam, 1983, Naloxone inaccessible σ receptor in rat central nervous system, 80, 6703 Tam, 1984, σ Opiates and certain other antipsychotic drugs mutually inhibit (+)[3H]SKF10,047 and [3H]haloperidol binding in guinea pig brain membranes, 81, 5618 Vincent, 1989, Interaction of phencyclidine (“angel dust”) with a specific receptor in rat brain membranes, 76, 4678 Zukin, 1979, Specific [3H]phencyclidine binding in rat central nervous system, 76, 5372 Zukin, 1981, Demonstration of [3H]cyclazocine binding to multiple opiate receptor sites, J. Molec. Pharmac., 20, 246